Postremission sequential monitoring of minimal residual disease by WT1 Q‐PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk‐adapted therapy in acute myeloid leukemia patients

Risk stratification in acute myeloid leukemia (AML) patients using prognostic parameters at diagnosis is effective, but may be significantly improved by the use of on treatment parameters which better define the actual sensitivity to therapy in the single patient. Minimal residual disease (MRD) moni...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Med
Main Authors: Malagola, Michele, Skert, Cristina, Borlenghi, Erika, Chiarini, Marco, Cattaneo, Chiara, Morello, Enrico, Cancelli, Valeria, Cattina, Federica, Cerqui, Elisa, Pagani, Chiara, Passi, Angela, Ribolla, Rossella, Bernardi, Simona, Giustini, Viviana, Lamorgese, Cinzia, Ruggeri, Giuseppina, Imberti, Luisa, Caimi, Luigi, Russo, Domenico, Rossi, Giuseppe
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2015
Assuntos:
Clinical Cancer Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4735778/
https://ncbi.nlm.nih.gov/pubmed/26715369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.593
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares